← All bills
HR 796In committeeHealthhouse
Second Chance for Moms Act
Introduced Jan 28, 2025 by Rep. Mary E. Miller
IntroducedCommitteeFloorCongressLaw
It's waiting on a committee vote to reach the full chamber. Most bills never leave this stage.
Latest action · Jan 28, 2025
Referred to the House Committee on Energy and Commerce.
What it does
This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
Summary by the Congressional Research Service.
Roll-call votes
No floor votes yet — it hasn't reached the floor of either chamber.